Genus Prime (532425)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹26.28 |
| Market Cap | ₹39.23 Cr |
| P/E Ratio | 62.27 |
| ROCE | -0.06% |
| ROE | 8.83% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 1,950% |
| 52-Week Range | ₹17.34 — ₹35.35 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹17.63 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
When I look at Genus Prime, I see a ₹39 crore micro-cap in a commodity chemicals business, and my first instinct is caution. The price is ₹26.28, which looks affordable, but value is not the same as price. The trailing P/E of 62.27 is very expensive for a company whose latest quarter reported sales of just ₹1 crore and net profit of ₹0 crore. Profit growth is flat at 0%, while sales growth of 1,950% sounds dramatic, but percentages from a tiny base can deceive; one crore rupees in a quarter is nothing in the chemicals industry.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer